# OnCo record idrx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/idrx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "idrx" ;
  schema:name "IDRx"@en ;
  schema:alternateName "IDRx, Inc."@en ;
  schema:description "IDRx, a Boston company, developed IDRX-42, a pill aimed at the KIT gene changes that drive most gastrointestinal stromal tumours (GIST). GSK bought the company in 2025."@en ;
  schema:url <https://onco.cc/companies/idrx/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1131399/000165495425000242/a0538t.htm>, <https://www.sec.gov/Archives/edgar/data/1131399/000165495425001815/a1769y.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/gist/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kit/> ;
  onco:drugs <https://onco.cc/drugs/idrx-42/> .